EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer

Joao M Alves, Nuria Estévez-Gómez, Roberto Piñeiro, Laura Muinelo-Romay, Patricia Mondelo-Macía, Mercedes Salgado, Agueda Iglesias-Gómez, Laura Codesido-Prada, Astrid Diez-Martín, Joaquin Cubiella, David Posada

Cellular Oncology · 06.10.2025 · 48 (6) · 1809-1820

DOI: 10.1007/s13402-025-01109-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 06.10.2025. Verfasst von Joao M Alves und 10 weiteren Autor:innen. Beteiligte Einrichtung: CINBIO, Universidade de Vigo, Vigo, 36310, Spain. jalves@uvigo.gal. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplastic Cells, Circulating, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Vigo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastatic colorectal cancer (mCRC) remains a major cause of cancer-related mortality, but few noninvasive biomarkers exist to track disease progression or inform treatment strategies. Circulating tumor cells (CTCs) offer a minimally invasive source of tumor material, yet the prognostic significance of their genomic diversity remains unclear.

Methods

We conducted whole-exome sequencing of CTC pools from 29 mCRC patients to characterize their mutational landscape and assess associations with overall survival.

Results

Our analysis revealed substantial variation in mutational burden among patients, with all CTC pools harboring non-silent mutations in key CRC driver genes. Higher genomic diversity in CTC pools was significantly associated with reduced overall survival. Additionally, non-silent mutations in BCL9L emerged as a strong predictor of patient survival.

Conclusion

Genomic diversity and BCL9L mutational status in CTC pools emerged as strong predictors of survival in mCRC, underscoring the potential of CTC genomic profiling as a minimally invasive and clinically relevant prognostic tool in mCRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNeoplastic Cells, CirculatingMutationHumansMaleFemaleMiddle AgedAgedPrognosisNeoplasm MetastasisAdultExome SequencingGenomics

Stichwörter der Autor:innen

Circulating tumor cellsColorectal cancerIntratumor genomic heterogeneityLiquid biopsyPrecision medicine

Autor:innen und Institutionen

  • CINBIO, Universidade de Vigo, Vigo, 36310, Spain. jalves@uvigo.gal.
  • Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain. jalves@uvigo.gal.
  • CINBIO, Universidade de Vigo, Vigo, 36310, Spain.
  • Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
  • Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Förderung

  • Universidade de Vigo

Zitieren

APA

Alves, J. M., Estévez-Gómez, N., Piñeiro, R., Muinelo-Romay, L., Mondelo-Macía, P., Salgado, M., Iglesias-Gómez, A., Codesido-Prada, L., Diez-Martín, A., Cubiella, J., & Posada, D. (2025). Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer. Cellular Oncology, 48(6), 1809-1820. https://doi.org/10.1007/s13402-025-01109-x

Vancouver

Alves JM, Estévez-Gómez N, Piñeiro R, Muinelo-Romay L, Mondelo-Macía P, Salgado M, et al. Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer. Cellular Oncology. 2025;48(6):1809-1820. doi:10.1007/s13402-025-01109-x

BibTeX
@article{Alves2025,
  author = {Alves, Joao M and Estévez-Gómez, Nuria and Piñeiro, Roberto and Muinelo-Romay, Laura and Mondelo-Macía, Patricia and Salgado, Mercedes and Iglesias-Gómez, Agueda and Codesido-Prada, Laura and Diez-Martín, Astrid and Cubiella, Joaquin and Posada, David},
  title = {Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {6},
  pages = {1809--1820},
  doi = {10.1007/s13402-025-01109-x}
}
Kostenlos starten →